GLAXOSMITHKLINE PLC 13D/13G Filings for CRISPR Therapeutics AG (CRSP)

GLAXOSMITHKLINE PLC 13D and 13G filings for CRISPR Therapeutics AG:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2020-07-10
5:26 pm
Purchase
2020-07-06 13D CRISPR Therapeutics AG
CRSP
GLAXOSMITHKLINE PLC 3,310,627
4.800%
15,000increase
(+0.46%)
Filing